PTC Therapeutics, Inc. (PTCT)

PTC Therapeutics Statistics

Total Valuation

PTCT has a market cap or net worth of $3.13 billion. The enterprise value is $4.52 billion.

Market Cap	3.13B
Enterprise Value	4.52B

Important Dates

The next confirmed earnings date is Tuesday, May 6, 2025, after market close.

Earnings Date	May 6, 2025
Ex-Dividend Date	n/a

Share Statistics

PTCT has 78.87 million shares outstanding. The number of shares has increased by 2.68% in one year.

Current Share Class	78.87M
Shares Outstanding	78.87M
Shares Change (YoY)	+2.68%
Shares Change (QoQ)	+0.36%
Owned by Insiders (%)	2.40%
Owned by Institutions (%)	81.62%
Float	63.20M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.87
Forward PS	4.16
PB Ratio	-2.92
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	5.61
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.35

Current Ratio	2.35
Quick Ratio	2.26
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-0.86

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-5.09%
Return on Invested Capital (ROIC)	-6.59%
Return on Capital Employed (ROCE)	-13.06%
Revenue Per Employee	$859,191
Profits Per Employee	-$386,896
Employee Count	939
Asset Turnover	0.45
Inventory Turnover	22.01

Taxes

In the past 12 months, PTCT has paid $176,000 in taxes.

Income Tax	176,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +22.08% in the last 52 weeks. The beta is 0.58, so PTCT's price volatility has been lower than the market average.

Beta (5Y)	0.58
52-Week Price Change	+22.08%
50-Day Moving Average	50.03
200-Day Moving Average	43.05
Relative Strength Index (RSI)	31.37
Average Volume (20 Days)	1,198,509

Short Selling Information

The latest short interest is 5.48 million, so 6.95% of the outstanding shares have been sold short.

Short Interest	5.48M
Short Previous Month	5.42M
Short % of Shares Out	6.95%
Short % of Float	8.67%
Short Ratio (days to cover)	4.72

Income Statement

In the last 12 months, PTCT had revenue of $806.78 million and -$363.30 million in losses. Loss per share was -$4.73.

Revenue	806.78M
Gross Profit	214.90M
Operating Income	-146.75M
Pretax Income	-494.07M
Net Income	-363.30M
EBITDA	-71.08M
EBIT	-146.75M
Loss Per Share	-$4.73

Balance Sheet

The company has $1.15 billion in cash and $2.47 billion in debt, giving a net cash position of -$1.32 billion or -$16.71 per share.

Cash & Cash Equivalents	1.15B
Total Debt	2.47B
Net Cash	-1.32B
Net Cash Per Share	-$16.71
Equity (Book Value)	-1.10B
Book Value Per Share	-14.13
Working Capital	784.55M

Cash Flow

In the last 12 months, operating cash flow was -$107.69 million and capital expenditures -$6.50 million, giving a free cash flow of -$114.19 million.

Operating Cash Flow	-107.69M
Capital Expenditures	-6.50M
Free Cash Flow	-114.19M
FCF Per Share	-$1.45

Margins

Gross margin is 26.64%, with operating and profit margins of -18.19% and -45.03%.

Gross Margin	26.64%
Operating Margin	-18.19%
Pretax Margin	-45.01%
Profit Margin	-45.03%
EBITDA Margin	-8.81%
EBIT Margin	-18.19%
FCF Margin	n/a

Dividends & Yields

PTCT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.68%
Shareholder Yield	-2.68%
Earnings Yield	-11.33%
FCF Yield	-3.56%

Analyst Forecast

The average price target for PTCT is $63.92, which is 61.01% higher than the current price. The consensus rating is "Buy".

Price Target	$63.92
Price Target Difference	61.01%
Analyst Consensus	Buy
Analyst Count	13
Revenue Growth Forecast (5Y)	14.33%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

PTCT has an Altman Z-Score of -1.69 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.69
Piotroski F-Score	3